AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, UK, according to reports from Reuters. The investment, which was anticipated to generate 1,000 new jobs, is currently on hold. The pharmaceutical company's decision indicates that none of its newly announced funding, initially revealed in March 2024, is moving forward at this time. Earlier this year, AstraZeneca shelved a separate £450m investment in a vaccine manufacturing plant in northern England, citing ...